Publications by authors named "Che-Min Lee"

Claim this Profile
D
Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an ILK-SFK-YAP signaling axis in lung adenocarcinoma.
Rocky Shi, Dylan A Farnsworth, Christopher A Febres-Aldana, Justine L M Chow, Ravinder Sheena, Che-Min Lee

Oncogene· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antihypertensive drugs and survival outcomes in oropharyngeal squamous cell carcinoma patients.
Che-Min Lee, Brennan J Wadsworth, Ryan Urban, Meredith A Clark, Rocky Shi

J Natl Cancer Inst· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-Associated Fibroblast Heterogeneity in Malignancy with Focus on Oral Squamous Cell Carcinoma.
Julia Arebro, Che-Min Lee, Kevin L Bennewith, Cathie Garnis

Int J Mol Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular vesicles promote activation of pro-inflammatory cancer-associated fibroblasts in oral cancer.
Julia Arebro, Rebecca Towle, Che-Min Lee, Kevin L Bennewith, Cathie Garnis

Front Cell Dev Biol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induced Vascular Normalization-Can One Force Tumors to Surrender to a Better Microenvironment?
Xu Xin Sun, Zeynab Nosrati, Janell Ko, Che-Min Lee, Kevin L Bennewith

Pharmaceutics· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transiently hypoxic tumour cell turnover and radiation sensitivity in human tumour xenografts.
Brennan J Wadsworth, Che-Min Lee, Kevin L Bennewith

Br J Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germinal center hypoxia in tumor-draining lymph nodes negatively regulates tumor-induced humoral immune responses in mouse models of breast cancer.
Natalie S Firmino, Rachel A Cederberg, Che-Min Lee, Rocky Shi, Brennan J Wadsworth

Oncoimmunology· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation.
Brennan J Wadsworth, Rachel A Cederberg, Che-Min Lee, Natalie S Firmino, S Elizabeth Franks

Cancer Lett· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis